Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-26-000031
Filing Date
2026-01-02
Accepted
2026-01-02 17:21:22
Documents
1
Period of Report
2026-01-02

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4283
  Complete submission text file 0001683168-26-000031.txt   5819
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Issuer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address
Dal Poggetto John (Reporting) CIK: 0001791040 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33216 | Film No.: 26503201